JP2014512353A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014512353A5 JP2014512353A5 JP2014501814A JP2014501814A JP2014512353A5 JP 2014512353 A5 JP2014512353 A5 JP 2014512353A5 JP 2014501814 A JP2014501814 A JP 2014501814A JP 2014501814 A JP2014501814 A JP 2014501814A JP 2014512353 A5 JP2014512353 A5 JP 2014512353A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- virus
- protein
- antiviral composition
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000840 anti-viral effect Effects 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 241000186359 Mycobacterium Species 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 239000004615 ingredient Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 claims 1
- 241000725619 Dengue virus Species 0.000 claims 1
- 241000991587 Enterovirus C Species 0.000 claims 1
- 241000711549 Hepacivirus C Species 0.000 claims 1
- 241000700721 Hepatitis B virus Species 0.000 claims 1
- 208000037018 Herpes simplex virus encephalitis Diseases 0.000 claims 1
- 241000710842 Japanese encephalitis virus Species 0.000 claims 1
- 241000712079 Measles morbillivirus Species 0.000 claims 1
- 241001529548 Megasphaera cerevisiae Species 0.000 claims 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 1
- 241000700584 Simplexvirus Species 0.000 claims 1
- 241000725681 Swine influenza virus Species 0.000 claims 1
- 230000021736 acetylation Effects 0.000 claims 1
- 238000006640 acetylation reaction Methods 0.000 claims 1
- 230000000903 blocking effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 230000006320 pegylation Effects 0.000 claims 1
- 230000026731 phosphorylation Effects 0.000 claims 1
- 238000006366 phosphorylation reaction Methods 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1126/MUM/2011 | 2011-03-31 | ||
| IN1126MU2011 | 2011-03-31 | ||
| PCT/IN2012/000153 WO2013072917A2 (en) | 2011-03-31 | 2012-03-05 | Antiviral composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014512353A JP2014512353A (ja) | 2014-05-22 |
| JP2014512353A5 true JP2014512353A5 (enExample) | 2015-04-23 |
Family
ID=48430291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014501814A Pending JP2014512353A (ja) | 2011-03-31 | 2012-03-05 | 抗ウイルス組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20140011735A1 (enExample) |
| EP (1) | EP2691106A4 (enExample) |
| JP (1) | JP2014512353A (enExample) |
| WO (1) | WO2013072917A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3154746B1 (en) | 2014-06-16 | 2017-09-27 | Swerea IVF AB | Impact machine |
| US20190382454A1 (en) * | 2015-03-05 | 2019-12-19 | Amrita Therapeutics Limited | A modified peptide as an anticancer agent |
| US12421626B2 (en) | 2018-06-29 | 2025-09-23 | Fred Hutchinson Cancer Center | Cell-stored barcoded deep mutational scanning libraries and uses of the same |
| US11821111B2 (en) | 2019-11-15 | 2023-11-21 | Fred Hutchinson Cancer Center | Barcoded influenza viruses and deep mutational scanning libraries including the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6087163A (en) * | 1997-02-06 | 2000-07-11 | The Public Health Research Institute Of The City Of New York, Inc. | Mycobacterium tuberculosis specific proteins and genes, mixtures of anitgens and uses thereof |
| DK1077711T3 (da) * | 1998-04-29 | 2005-05-23 | Medac Klinische Spezialpraep | Behandling af papillomavirusinfektion under anvendelse af en mycobakterie |
| EP1766096B1 (en) * | 2004-05-25 | 2013-01-02 | Oregon Health and Science University | Hiv vaccination usingand hcmv-based vaccine vectors |
| JP2006149234A (ja) * | 2004-11-25 | 2006-06-15 | Japan Science & Technology Agency | プライム−ブーストワクチン接種法 |
| JP5246730B2 (ja) * | 2006-12-08 | 2013-07-24 | 独立行政法人理化学研究所 | Ｔｈ１細胞分化促進剤 |
| WO2009039854A2 (en) * | 2007-09-27 | 2009-04-02 | Dako Denmark A/S | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| JP5873499B2 (ja) * | 2010-10-01 | 2016-03-01 | アムリタ セラピューティクス リミテッドＡｍｒｉｔａ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | 抗がん剤 |
-
2012
- 2012-03-05 WO PCT/IN2012/000153 patent/WO2013072917A2/en not_active Ceased
- 2012-03-05 US US14/005,756 patent/US20140011735A1/en not_active Abandoned
- 2012-03-05 EP EP12850210.1A patent/EP2691106A4/en not_active Withdrawn
- 2012-03-05 JP JP2014501814A patent/JP2014512353A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018550201A1 (en) | Hepatitis b antiviral agents | |
| MX2012007410A (es) | Compuestos antivirales novedosos. | |
| JP2018523668A5 (enExample) | ||
| EA201171376A1 (ru) | Производные тиено[2,3-b]пиридина в качестве ингибиторов репликации вируса | |
| JP2015096557A5 (enExample) | ||
| PH12018550148A1 (en) | Hepatitis b antiviral agents | |
| MX2013005478A (es) | Compuestos heterociclicos condensados antivirales. | |
| CN114901681A (zh) | 胰岛素衍生物 | |
| PH12020550065A1 (en) | Hepatitis b antiviral agents | |
| ME02400B (me) | Policiklična karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba | |
| RU2015109132A (ru) | Пролекарственная форма тенофовира и ее фармацевтические применения | |
| IN2014MN01547A (enExample) | ||
| JP2017515901A5 (enExample) | ||
| JP2013542224A5 (enExample) | ||
| EA201591213A1 (ru) | Вакцины против вируса гепатита b | |
| GB2503066A8 (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
| BR112013028679A2 (pt) | inibidores do vírus da hepatite c | |
| JP2014532722A5 (enExample) | ||
| JP2014512353A5 (enExample) | ||
| WO2011091319A3 (en) | Dendritic cell vaccines | |
| JP2018531880A5 (enExample) | ||
| EA201491969A1 (ru) | Иммуногенные соединения, включающие пептид gp41 вич, связанный с белком-носителем crm197 | |
| JP2013542196A5 (enExample) | ||
| WO2007137591A3 (en) | Hiv vaccine | |
| US20140011735A1 (en) | Antiviral composition |